期刊
CURRENT OPINION IN CHEMICAL BIOLOGY
卷 13, 期 3, 页码 303-308出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.cbpa.2009.04.619
关键词
-
资金
- MIUR [20073EWPF9 003]
- University of Bologna
In this work, we review and comment upon the challenges and the 'quo vadis' in Alzheimer's disease drug discovery at the beginning of the new millennium. We emphasize recent approaches that, moving on from a target-centric approach, have produced innovative molecular probes or drug candidates. In particular, the discovery of endosome-targeted BACE1 inhibitors and mitochondria-targeted antioxidants represents a significant advance in Alzheimer's research and therapy. The case study of the development of rasagiline provides an excellent example to support the validity of the multitarget-designed ligand approach to the search for effective medicines for combating Alzheimer's disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据